We are pleased to announce that Switzerland is now fully available in ECRIN’s Regulatory & Ethical Database (RED), further expanding access to essential regulatory and ethical information for clinical research in Europe and beyond.

RED serves as a central access point for national regulatory and ethical requirements for clinical research across Europe. Designed to support a wide range of study types and countries, the database helps researchers navigate the European clinical research landscape more efficiently and in alignment with the Clinical Trials Regulation (CTR).

Why Switzerland in RED?

Switzerland has a distinct regulatory system for clinical studies and is not part of the EU Clinical Trials Information System (CTIS). For sponsors and investigators planning studies in or including Switzerland, access to clear, structured, and country-specific guidance is therefore particularly important.

With Switzerland now integrated into RED, users can:

• Access detailed information on national regulatory and ethical requirements
• Identify competent authorities and ethics committees
• Better anticipate submission pathways outside the CTIS framework
• Navigate Swiss-specific processes with greater clarity and confidence

Supporting compliance across Europe

RED continues to support non-commercial sponsors and investigators by facilitating compliance and providing reliable, up-to-date guidance tailored to national contexts. By offering structured regulatory intelligence, RED helps the clinical research community navigate complexity more efficiently.

Explore Switzerland in RED.